{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:02:10Z","timestamp":1759564930131},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejogrb.2018.01.020","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T11:20:32Z","timestamp":1517656832000},"page":"84-88","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs"],"prefix":"10.1016","volume":"222","author":[{"given":"Brigitta","family":"Badiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Chiumente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Messori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejogrb.2018.01.020_bib0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2018.01.020_bib0010","series-title":"Agenzia Italiana del Farmaco [Internet]","author":"AIFA","year":"2018"},{"issue":"2","key":"10.1016\/j.ejogrb.2018.01.020_bib0015","doi-asserted-by":"crossref","first-page":"e0149631","DOI":"10.1371\/journal.pone.0149631","article-title":"Medical therapies for uterine fibroids \u2013 a systematic review and network meta-analysis of randomised controlled trials","volume":"11","author":"Gurusamy","year":"2016","journal-title":"PLoS One"},{"issue":"January","key":"10.1016\/j.ejogrb.2018.01.020_bib0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.maturitas.2016.10.012","article-title":"Medical or surgical management of fibroids? An internet survey of gynecologists\u2019 views","volume":"95","author":"Pazzaglia","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.ejogrb.2018.01.020_bib0025","series-title":"Pearl-I trial: Incremental Benefit Between Patients Treated with Ulipristal 5\u2009mg\/day and Those Receiving Placebo","author":"Messori","year":"2017"},{"key":"10.1016\/j.ejogrb.2018.01.020_bib0030","series-title":"Methods for the Economic Evaluation of Health Care Programme","author":"Drummond","year":"2015"},{"key":"10.1016\/j.ejogrb.2018.01.020_bib0035","unstructured":"ISTAT, Tavole di mortalit\u00e0 della popolazione italiana\u2014Ripartizione: Italia \u2013 Femmine \u2013 Anno: 2014, http:\/\/demo.istat.it\/unitav2012\/index.html?lingua=ita [Accessed 7 August 2017]."},{"issue":"1","key":"10.1016\/j.ejogrb.2018.01.020_bib0040","first-page":"15","article-title":"Repeated-intermittent use of ulipristal acetate for the management of uterine fibroids: an Italian pharmacoeconomic evaluation","volume":"68","author":"Maratea","year":"2016","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.ejogrb.2018.01.020_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2014.01.022","article-title":"The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids","volume":"175","author":"Nagy","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.ejogrb.2018.01.020_bib0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5301\/GRHTA.5000223","article-title":"Clinical and economic management of uterine fibroids: the point of view of a decision makers board","volume":"3","author":"Di Carlo","year":"2016","journal-title":"Global Region Health Technol Assess"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518300307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211518300307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T19:27:28Z","timestamp":1721330848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211518300307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":10,"alternative-id":["S0301211518300307"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.01.020","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2018.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}